With posthumous recognition and appreciation for his tremendous contribution, the University of Oklahoma Department of Dermatology will now be known as the Mark Allen Everett Department of Dermatology.
A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug cisplatin.